Photo Credit: CooperVision
CooperVision, a world-renowned leader in myopia management and a global contact lens manufacturer, has successfully concluded its highly anticipated 3rd Asia-Pacific Myopia Management Symposium (APMMS).
Held on 10 December 2023, at Marriott Taipei, the flagship event gathered more than 2,000 eye care experts in-person and virtually across the globe, including from the United States and the United Kingdom, as well as from key myopia epicenters such as Taiwan, Singapore, South Korea, and Japan.
The symposium fostered discussions on the growing prevalence of myopia, emerging interventions
for disease management, and best practices in myopia care, paving the way forward in establishing myopia management as the standard of care, both within Asia and beyond.
The symposium commenced with opening addresses delivered by prominent eye care leaders: Dr. Lin Pi Jung, President, Universal Eye Center; Dr. Wu Pei Chang, Director, Myopia Treatment and Prevention Center and Professor, Chang Gun Memorial University; and Ms. Kathy Park, President, CooperVision Asia Pacific. Together, they articulated a shared vision to construct a myopia-resilient future encompassing the exploration of new interventions, knowledge exchange, and collaboration.
The thought-provoking sharing of the leaders set an influential tone for a series of enlightening sessions that followed during the full-day event. Reflecting on the success of the event, Shila Gupta, Myopia Management General Manager, CooperVision Asia-Pacific, expressed excitement about the symposium’s profound impact: “As myopia prevalence rises in Asia-Pacific, APMMS 2023 has emerged as a beacon for myopia management, advocating the need for intervention strategies. As the landscape of myopia care continues to evolve, we are confident that APMMS will serve as a nexus for the global community
and lead vital conversations in the field of myopia management. At CooperVision, we are committed to supporting solutions that will shape the future of myopia management in the region and globally.”
A series of presentations from ophthalmology experts across the globe presented their respective national strategies in myopia prophylaxis, discussed case studies & clinical studies around the disease. The global experts shared their insights over the enthralling panel discussions around significant issues of Myopia such as,
Dr. Lin Pi Jung, CEO, Universal Eye Center said, “APMMS 2023 has not only marked a significant milestone in our collective journey to combat myopia but also solidified Taiwan's role as a hub for knowledge exchange in myopia research. As the official partner for this symposium, Universal Eye Center is proud to contribute to the global dialogue on myopia management. We believe that collaboration, innovation, and shared insights are key to addressing the challenges posed by myopia. Through events like APMMS, we are committed to fostering an environment where industry leaders, experts, and researchers come together to shape the future of myopia care. Our partnership with CooperVision underscores our shared dedication to make a positive impact on eye health worldwide.”
Through APMMS, CooperVision aims to lead discussions on myopia, best practices within its management, and clinical insights that can advance the care and treatment of the disease. The strategic collaboration with industry leaders, including Universal Eye Center this year, underscores CooperVision’s commitment to addressing the multifaceted challenges posed by myopia. CooperVision remains dedicated to providing innovative myopia management solutions. APMMS concluded with a renewed sense of urgency and commitment to address the growing prevalence of myopia across Asia, fostering collaboration and innovation to shape the future of myopia management in the region
